MK7962-038_MERCK SOTERIA - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)
Principal Investigator
Terry A. Fortin, MD, MS
Cardiologist
Protocol Number
IRB:
PRO00118560
NCT:
NCT07218029
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment